Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection

Fig. 2

Patient survival according to tumor budding. a Disease specific survival. b Recurrence free survival. On both disease specific survival (DSS) and recurrence free survival (RFS), patients in high TB group had significantly poor survival compared to patients in low TB group (p < 0.001 in DSS, p = 0.001 in RFS). Interestingly, DSS in high TB group did not show statistical difference compared to that in 28 unresected patients at our institution in the same period (p = 0.103). *Eleven patients with R2 resection (distant metastasis or cancer positive surgical margin) were excluded from RFS study

Back to article page
\